Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein
- PMID: 14990742
- PMCID: PMC353748
- DOI: 10.1128/jvi.78.6.3196-3199.2004
Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein
Abstract
We generated an attenuated, recombinant vesicular stomatitis virus (VSV) expressing high levels of the cottontail rabbit papillomavirus (CRPV) L1 protein from an upstream site in the VSV genome. Rabbits vaccinated once with this VSV-L1 recombinant produced high levels of anti-L1 antibody and were completely protected against papilloma formation after challenge with CRPV. In contrast, animals vaccinated only once with a VSV vector expressing lower levels of L1 from a downstream site in the VSV genome generated lower levels of L1 antibody and demonstrated only incomplete protection from papilloma formation after challenge. We conclude that the level of L1 protein expression is critical in generating complete immunity with a single-dose vaccine.
Figures
Similar articles
-
Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease.J Virol. 2002 Sep;76(17):8900-9. doi: 10.1128/jvi.76.17.8900-8909.2002. J Virol. 2002. PMID: 12163609 Free PMC article.
-
Protective cell-mediated immunity by DNA vaccination against Papillomavirus L1 capsid protein in the Cottontail Rabbit Papillomavirus model.Viral Immunol. 2006 Summer;19(3):492-507. doi: 10.1089/vim.2006.19.492. Viral Immunol. 2006. PMID: 16987067
-
Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus.J Virol. 2007 Jun;81(11):5749-58. doi: 10.1128/JVI.02835-06. Epub 2007 Mar 28. J Virol. 2007. PMID: 17392369 Free PMC article.
-
[Vesicular stomatitis virus (VSV) as a vaccine vector for immunization against viral infections].Postepy Hig Med Dosw (Online). 2013 Jan 11;67:1345-58. doi: 10.5604/17322693.1083016. Postepy Hig Med Dosw (Online). 2013. PMID: 24379275 Review. Polish.
-
Development of an HIV vaccine using a vesicular stomatitis virus vector expressing designer HIV-1 envelope glycoproteins to enhance humoral responses.AIDS Res Ther. 2017 Sep 12;14(1):55. doi: 10.1186/s12981-017-0179-2. AIDS Res Ther. 2017. PMID: 28893277 Free PMC article. Review.
Cited by
-
The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.J Virol. 2012 Apr;86(8):4253-61. doi: 10.1128/JVI.05991-11. Epub 2012 Feb 15. J Virol. 2012. PMID: 22345454 Free PMC article.
-
The current status and future directions of myxoma virus, a master in immune evasion.Vet Res. 2011 Jun 9;42(1):76. doi: 10.1186/1297-9716-42-76. Vet Res. 2011. PMID: 21658227 Free PMC article. Review.
-
A novel borna disease virus vector system that stably expresses foreign proteins from an intercistronic noncoding region.J Virol. 2011 Dec;85(23):12170-8. doi: 10.1128/JVI.05554-11. Epub 2011 Sep 21. J Virol. 2011. PMID: 21937656 Free PMC article.
-
Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA Vaccination.Sci Rep. 2016 Sep 23;6:33564. doi: 10.1038/srep33564. Sci Rep. 2016. PMID: 27658623 Free PMC article.
-
Development and Applications of VSV Vectors Based on Cell Tropism.Front Microbiol. 2012 Jan 18;2:272. doi: 10.3389/fmicb.2011.00272. eCollection 2011. Front Microbiol. 2012. PMID: 22279443 Free PMC article.
References
-
- Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenmacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963. - PMC - PubMed
-
- Haglund, K., J. Forman, H. G. Krausslich, and J. K. Rose. 2000. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope. Virology 268:112-121. - PubMed
-
- Iverson, L. E., and J. K. Rose. 1981. Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell 23:477-484. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources